BioGaia AB

BGLA

Company Profile

  • Business description

    BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).

  • Contact

    Kungsbroplan 3A
    StockholmSE-112 27
    SWE

    T: +46 855529300

    E: [email protected]

    https://www.biogaiagroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    251

Stocks News & Analysis

stocks

SpaceX is scaling AI infrastructure on earth, data centers in space might be next

Our view on the first results as a publicly traded company.
stocks

Investors too optimistic about overvalued ASX share

Upgraded first-half revenue guidance at the upper end of the previously announced range.
stocks

Restructuring at big four bank

Job cuts create capacity to invest as revenue growth slows.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,956.6012.400.14%
CAC 407,921.6883.191.06%
DAX 4025,645.04340.621.35%
Dow JONES (US)52,856.09360.210.69%
FTSE 10010,752.8819.880.19%
HKSE23,651.87215.87-0.90%
NASDAQ26,702.86278.041.05%
Nikkei 22564,621.24545.820.85%
NZX 50 Index13,761.290.000.00%
S&P 5007,757.1744.600.58%
S&P/ASX 2008,831.3014.400.16%
SSE Composite Index3,713.0322.34-0.60%

Market Movers